Ultragenyx Pharmaceutical, Inc. (RARE)
22.51
-0.70
(-3.02%)
USD |
NASDAQ |
Jan 09, 16:00
22.50
-0.01
(-0.04%)
After-Hours: 05:44
Ultragenyx Pharmaceutical Accounts Payable (Quarterly): 40.57M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Johnson & Johnson | 9.625B |
| CorMedix, Inc. | 20.45M |
| Amicus Therapeutics, Inc. | 19.10M |
| Geron Corp. | 11.11M |
| Insmed, Inc. | 79.59M |